RELX:NYSERELX PLC PLC Analysis
Data as of 2026-09-01 - not real-time
$35.70
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
RELX PLC is priced at $35.70, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 9.1%. Momentum indicators put RSI at 52.4 (neutral) with MACD reading bullish. Recent trading has carved out support near $33.56 and resistance around $37.48.
The shares look fair, trading on 21.0 times earnings below a sector average of 28.6. Consensus targets land 48.6% above where the shares trade now. Revenue is growing at 2.7% on a 23.3% profit margin. The 2.50% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 36.6%, a beta of 0.27 and a maximum drawdown of 41.9%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
The shares look fair, trading on 21.0 times earnings below a sector average of 28.6. Consensus targets land 48.6% above where the shares trade now. Revenue is growing at 2.7% on a 23.3% profit margin. The 2.50% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 36.6%, a beta of 0.27 and a maximum drawdown of 41.9%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
Top Market Events
LONDON dpa-AFX - RELX Plc RELX, RLXXF.PK, REL.L , a provider of information-based analytics and decision tools,...RELX plc stock attracts attention as investors focus on the companys data and analytics business modSeeking Alpha1monRELX PLC: Legal And STM Accelerate As Valuation Got CheaperRELX PLC maintains robust,...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 35.53
- MACD momentum is positive
- 30-day price change of +9.1%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 21.0 versus sector average of 28.6
- Trading above the 200-day average of 35.53
- Analyst targets imply +48.6% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 21.0 versus sector average of 28.6
- Analyst targets imply +48.6% versus the current price
- Profit margin of 23.3% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth2.70%
Profit Margin23.27%
P/E Ratio21.0
ROE131.86%
ROA13.12%
Debt/Equity709.64
P/B Ratio148.3
Op. Cash Flow$2.9B
Free Cash Flow$2.2B
Industry P/E28.6
Technical Analysis
TrendNeutral
RSI52.4
Support$33.56
Resistance$37.48
MA 20$35.48
MA 50$34.26
MA 200$35.53
MACDBullish
VolumeDecreasing
Fear & Greed Index92.25
Valuation
Fair Value$13.29
Target Price$53.05
Upside/Downside48.60%
GradeFair
TypeBlend
Dividend Yield2.50%
Risk Assessment
Beta0.27
Volatility36.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.